Clinical Trial Update: A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 randomized proof-of-principle trial evaluated the pharmacodynamics, pharmacokinetics, and safety of NNC0143-0406 in subjects with Type 1 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0143-0406

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED